Clinical Trials Insight: 700036437
Latest Information Update: 20 Aug 2008
Price :
$35 *
At a glance
- Drugs Sparsentan (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- Sponsors Pharmacopeia
- 20 Aug 2008 New trial record.
Latest Information Update: 20 Aug 2008